Skip to main
UNH
UNH logo

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 23 analyst ratings
Buy
Strong Buy 26%
Buy 57%
Hold 9%
Sell 9%
Strong Sell 0%

Bulls say

UnitedHealth Group's substantial scale in medical insurance, with approximately 51 million members globally, positions the company as a leader in the health insurance market, contributing to its robust competitive advantage. The Optum business segment is identified as a key differentiator that effectively lowers medical cost trends, while also benefiting from site of service re-direction, further enhancing operational efficiency. Additionally, a sizable balance sheet coupled with strong free cash flow indicates a solid financial foundation, enabling capital deployment that is expected to bolster already impressive core trends in the business.

Bears say

A negative outlook on UnitedHealth Group's stock is primarily driven by its significant exposure to government contracts, which can introduce volatility and regulatory challenges. Additionally, persistent high levels of care activity trends may exert pressure on margins and operational efficiencies. The company's struggles with acquisition integration and an increasingly competitive landscape further heighten the risk profile, potentially impacting its growth and market position.

UnitedHealth Group (UNH) has been analyzed by 23 analysts, with a consensus rating of Buy. 26% of analysts recommend a Strong Buy, 57% recommend Buy, 9% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 23 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $392.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $392.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.